Skip to main content
U.S. Department of Energy
Office of Scientific and Technical Information

Structural basis for GPR40 allosteric agonism and incretin stimulation

Journal Article · · Nature Communications

Research Organization:
Argonne National Lab. (ANL), Argonne, IL (United States). Advanced Photon Source (APS)
Sponsoring Organization:
INDUSTRY
OSTI ID:
1474161
Journal Information:
Nature Communications, Vol. 9, Issue 1; ISSN 2041-1723
Publisher:
Nature Publishing Group
Country of Publication:
United States
Language:
ENGLISH

References (34)

[19] Integrated methods for the construction of three-dimensional models and computational probing of structure-function relations in G protein-coupled receptors January 1995
Structural Diversity in Conserved Regions Like the DRY-Motif among Viral 7TM Receptors—A Consequence of Evolutionary Pressure? January 2012
Gpr40 Is Expressed in Enteroendocrine Cells and Mediates Free Fatty Acid Stimulation of Incretin Secretion June 2008
Overview of the CCP 4 suite and current developments March 2011
Modulating GPR40: therapeutic promise and potential in diabetes December 2013
MolProbity : all-atom structure validation for macromolecular crystallography December 2009
Two disparate ligand-binding sites in the human P2Y1 receptor March 2015
Crystal structure of the β2 adrenergic receptor–Gs protein complex July 2011
Recent developments in the discovery of FFA1 receptor agonists as novel oral treatment for type 2 diabetes mellitus July 2014
High-resolution structure of the human GPR40 receptor bound to allosteric agonist TAK-875 July 2014
Features and development of Coot March 2010
Structural basis for the cooperative allosteric activation of the free fatty acid receptor GPR40 June 2017
REFMAC 5 for the refinement of macromolecular crystal structures March 2011
The Orphan G Protein-coupled Receptor GPR40 Is Activated by Medium and Long Chain Fatty Acids December 2002
Electric Moments of Molecules in Liquids August 1936
Monte Carlo studies of the dielectric properties of water-like models September 1973
Solvent-accessible surfaces of proteins and nucleic acids August 1983
Free fatty acids regulate insulin secretion from pancreatic β cells through GPR40 February 2003
Identification and Pharmacological Characterization of Multiple Allosteric Binding Sites on the Free Fatty Acid 1 Receptor August 2012
TAK-875 versus placebo or glimepiride in type 2 diabetes mellitus: a phase 2, randomised, double-blind, placebo-controlled trial April 2012
A Cluster of Aromatic Amino Acids in the i2 Loop Plays a Key Role for G s Coupling in Prostaglandin EP2 and EP3 Receptors December 2003
Microscale Fluorescent Thermal Stability Assay for Membrane Proteins March 2008
Data processing and analysis with the autoPROC toolbox March 2011
Scaling and assessment of data quality December 2005
Crystallizing membrane proteins using lipidic mesophases April 2009
Extra-helical binding site of a glucagon receptor antagonist April 2016
GPR40 (FFAR1) – Combined Gs and Gq signaling in vitro is associated with robust incretin secretagogue action ex vivo and in vivo January 2015
Integration, scaling, space-group assignment and post-refinement January 2010
MAB, a generally applicable molecular force field for structure modelling in medicinal chemistry June 1995
Allosteric Modulation of Endogenous Metabolites as an Avenue for Drug Discovery May 2012
International Union of Pharmacology. LXXI. Free Fatty Acid Receptors FFA1, -2, and -3: Pharmacology and Pathophysiological Functions December 2008
The Minimum Significant Ratio: A Statistical Parameter to Characterize the Reproducibility of Potency Estimates from Concentration-Response Assays and Estimation by Replicate-Experiment Studies April 2006
Treatment of Type 2 Diabetes by Free Fatty Acid Receptor Agonists August 2014
A Novel Antidiabetic Drug, Fasiglifam/TAK-875, Acts as an Ago-Allosteric Modulator of FFAR1 October 2013

Similar Records

Related Subjects